Albert David Limited (ALBERTDAVD) Financial History

Name: Albert David Limited (ALBERTDAVD) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Albert David Limited (ALBERTDAVD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kolkata, India with about 1,476 employees. Its market capitalization is roughly ₹5 billion. In the fiscal year ended 2026-03-31, ALBERTDAVD reported ₹3.3B in revenue and (₹15M) in net income.

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, and vision care products.

Interactive charts & full statements →

ALBERTDAVD Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹3.3B	₹3.4B	₹3.6B	₹3.4B
Gross Profit	₹2.1B	₹2.2B	₹2.3B	₹2.1B
Operating Income (EBIT)	₹1M	(₹28M)	₹410M	₹365M
Net Income	(₹15M)	₹172M	₹754M	₹362M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALBERTDAVD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹1.0B	₹859M	₹899M	₹872M	₹706M	—
Gross Profit	₹652M	₹558M	₹621M	₹566M	₹453M	—
Operating Income (EBIT)	₹84M	₹0M	₹84M	₹3M	(₹130M)	—
Net Income	₹320M	(₹214M)	₹153M	(₹33M)	₹79M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALBERTDAVD Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹29M)	(₹66M)	(₹52M)	(₹52M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ALBERTDAVD Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹5.2B	₹5.1B	₹5.0B	₹4.2B	—
Total Liabilities	₹1.3B	₹1.2B	₹1.2B	₹1.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALBERTDAVD viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

6185 · CanSino Biologics Inc. — HK$7 billion
0570 · China Traditional Chinese Medicine Holdings Co. Limited — HK$6 billion
4539 · Nippon Chemiphar Co., Ltd. — JPY 6 billion
2575 · Xuanzhu Biopharmaceutical Co., Ltd. — HK$5 billion
3613 · Beijing Tong Ren Tang Chinese Medicine Company Limited — HK$5 billion
MEDICAMEQ · Medicamen Biotech Limited — ₹4 billion
TMAN · T.Man Pharmaceutical Public Company Limited — THB 4 billion
CURA · Curaleaf Holdings, Inc. — C$4 billion

← ALBA All “A” companies ALBG →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.